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Abstract: Alzheimer’s disease (AD) is the most common form of dementia among older 
people and the pathogenesis of this disease is associated with oxidative stress. 
Acetylcholinesterase inhibitors with antioxidant activities are considered potential 
treatments for AD. Some novel ketone derivatives of gallic hydrazide-derived Schiff bases 
were synthesized and examined for their antioxidant activities and in vitro and in silico 
acetyl cholinesterase inhibition. The compounds were characterized using spectroscopy 
and X-ray crystallography. The ferric reducing antioxidant power (FRAP) and  
2,2-diphenyl-1-picrylhydrazyl (DPPH) assays revealed that all the compounds  
have strong antioxidant activities. N-(1-(5-bromo-2-hydroxyphenyl)-ethylidene)-3,4,5-
trihydroxybenzohydrazide (2) was the most potent inhibitor of human acetyl 
cholinesterase, giving an inhibition rate of 77% at 100 μM. Molecular docking simulation 
of the ligand-enzyme complex suggested that the ligand may be positioned in the enzyme’s 
active-site gorge, interacting with residues in the peripheral anionic subsite (PAS) and acyl 
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binding pocket (ABP). The current work warrants further preclinical studies to assess the 
potential for these novel compounds for the treatment of AD. 
Keywords: gallic hydrazide Schiff bases; AChE inhibition; antioxidant study;  
molecular docking 
 
1. Introduction 
The chemistry of hydrazones is an intensive area of study and numerous Schiff base ligands and their 
complexes of this type have been synthesized and their biological applications reported [1–5]. The major 
antioxidants currently used in foods are monohydroxy or polyhydroxy phenol compounds with various 
ring substitutions. These compounds have low activation energy for hydrogen donation [6]. Mainly from  
in vitro studies, polyphenols have been reported to have antioxidant [6–8], anti-cancer [9,10] and 
cardioprotecive activities [11]. 
Antioxidants such as vitamins A, E and C prevent the formation of free radicals and/or neutralize 
those that are formed, thus they break radical chains. They also repair the damage caused by free 
radicals, such as the DNA repair enzymes, e.g., transferases. Natural antioxidants are present in foods, 
but synthetic antioxidants may either be added to food to extend its shelf-life, or prepared by extraction 
from plant sources to be taken as supplements in concentrated form [8]. A number of studies have 
investigated a range of antioxidant agents in the hope of finding better and more effective treatments 
against AD [12]. Work has tended to focus on dietary antioxidants such as vitamins A, C, and E. 
Though these appear to have some benefits, results have proved frustratingly inconclusive [13]. 
Studies of many other dietary antioxidants polyphenols have also shown promise but, once more, their 
worth is yet unproven [14]. 
Researchers have recently investigated the potential health benefits of polyphenols in organic 
product [15]. Increased consumption of polyphenols has been associated with a reduced risk of 
cardiovascular disease and possibly cancer and stroke. Laboratory findings have shown that oxidative 
stress may play an important role to the pathogenesis of AD. Therefore, the risk of AD disease might 
be decreased by intake of antioxidants that neutralize the unfavorable effects of oxidative stress [16]. 
The present work reports the synthesis, characterization, antioxidants activities and X-ray crystal 
structures of Schiff bases derived from the condensation reaction of gallic hydrazide with pyridine and 
acetophenone derivatives, together with their acetylcholinesterase inhibition and antioxidant activity. 
2. Results and Discussion 
2.1. Chemistry 
The reaction of gallic hydrazide (1) with selected hydroxyacetophenones and pyridine derivatives 
resulted in the formation of the corresponding polyphenolic compounds: N-(1-(5-Bromo-2-
hydroxyphenyl)-ethylidene)-3,4,5-trihydroxybenzohydrazide (2); N-(1-(5-Chloro-2-hydroxyphenyl)-
ethylidene)-3,4,5-trihydroxybenzohydrazide (3); N-(1-(2-Hydroxy-5-methoxyphenyl)-ethylidene)-3,4,5- 
trihydroxybenzohydrazide (4); 3,4,5-Trihydroxybenzoic acid [1-pyridylethylidene] hydrazide (5); 
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3,4,5-Trihydroxybenzoic acid [1-(4-acetyl-pyridin-2-yl)-ethylidene] hydrazide (6) (Scheme 1). Their 
NMR, IR and UV-visible spectra were all consistent with the proposed structures. 
Scheme 1. Reaction pathways. 
HO
HO
HO
O
HN NH2
HO
HO
HO
O
OCH3
NH3+H2N
O
N X
O
HO
X
HO
HO
HO
O
HN N
HO
X
Where 
X = Br (2)
    = Cl (3) 
    = O-CH3 (4)
HO
HO
HO
O
HN N
N
XWhere 
X = H (5)
    = CH3CO (6)
(1)
 
The IR spectra of compounds 2–6 revealed the presence of both characteristic ketonic carbonyl 
absorptions (at wavenumbers of 1,618, 1,650, 1,674, 1,638 and 1,658 cm−1 respectively) and imine 
absorptions [17,18] (at wavenumbers of 1,621, 1,623, 1,610, 1,604, and 1,604 cm−1 respectively), thus 
confirming the formation of Schiff bases. The broad bands observed in the 3,570–3,390 cm−1 range 
were attributed to the phenolic hydroxyl groups [19]. Other series of bands in the wavenumber ranges 
3,360–3,220 cm−1 and 1,110–950 cm−1 were assigned to υ(N-H) aliphatic and υ(N-N) stretching 
vibrations, respectively [20,21]. The 1H-NMR spectra of the Schiff bases revealed a singlet at δ 1.24, 
1.24, 1.19, 2.12 and 1.24 ppm, respectively, which is due to a methyl group shielded by the imine 
moiety. Compound 4 also showed another singlet at δ 3.75 which was attributed to the methoxyl 
group. In the 13C-NMR spectra the signals in the range 167–152 ppm could be assigned to the 
azomethine carbon atoms [3]. 
2.2. X-ray Crystallography 
The ORTEP view of the crystal structure of compound 4 is shown in Figure 1, and selected bonding 
parameters are listed in Table 1. The N1-N2 1.375(4), N1 = C8 1.294(4) and N2-C10 1.374(4) bond 
distances show no significant differences with those obtained previously for compound 2 [22]. For the 
description of the X-ray crystal geometry of the ligands, the molecule is proposed to be a planar or flat 
molecule. Planarity of the molecule makes it possible for the proton to be transferred through the 
hydrogen bond in the ground state with a small energy requirement. 
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Figure 1. ORTEP-type view of the crystal structure of compound 4 showing the labeling 
scheme. Thermal ellipsoids are drawn at the 50% probability level. 
 
Table 1. Selected bond distances (Å) and angles (°) for compound 4. 
Distances
N1-N2 1.375(4)
N1-C8 1.294(4)
N2-C10 1.374(4)
C10-O3 1.231(4)
Angles
C8-N1-N2 121.0(3) 
C10-N2-N1 116.6(3)
O3-C10-N2 120.5(3)
O2-C5-C6 123.0(3)
The crystal data and structure refinement for compound 4 is summarized in Table 2. 
Table 2. Crystal data and structure refinement for 4 and 5. 
Identification code 4 5 
Empirical formula  C16H18N2O7 C14H12N3O5  
Formula weight  350.32 302.27  
Temperature/K  569(2) 296.0  
Crystal system  Monoclinic triclinic  
Space group  P21/n P-1  
a/Å  7.769(9) 6.6282(7)  
b/Å  15.509(19) 9.9326(7)  
c/Å  13.162(16) 12.8906(11)  
α/°  90.00 79.982(2)  
β/°  103.85(2) 80.995(2)  
γ/°  90.00 76.5060(10)  
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Table 2. Cont. 
Identification code 4 5 
Volume/Å3  1,540(3) 806.67(12)  
Z  4 2  
ρcalcmg/mm3  1.511 1.244  
m/mm-1  0.120 0.097  
F(000)  736 314.0  
Crystal size/mm3  0.28 × 0.05 × 0.01 0.33 × 0.14 × 0.11  
2Θ range for data collection  4.14 to 50° 3.24 to 61.08°  
Index ranges  −5 ≤ h ≤ 9, −18 ≤ k ≤ 18, −15 ≤ l ≤ 14 −8 ≤ h ≤ 6, −14 ≤ k ≤ 10, −17 ≤ l ≤ 17 
Reflections collected  7,052 2,552  
Independent reflections  2,704[R(int) = 0.0721] 2,237[R(int) = 0.0358]  
Data/restraints/parameters  2,704/3/241 2,237/12/254  
Goodness-of-fit on F2  0.986 0.804  
Final R indexes [I >= 2σ (I)]  R1 = 0.0532, wR2 = 0.1121 R1 = 0.0462, wR2 = 0.1239  
Final R indexes [all data]  R1 = 0.1117, wR2 = 0.1358 R1 = 0.0555, wR2 = 0.1354  
Largest diff. peak/hole/e Å−3  0.305/−0.264 0.43/−0.34  
2.3. Anti-AChE Assay 
The inhibitory activities of compounds 1–6 on human acetyl cholinesterase were in the range of  
16–77% at 100 μM (see Table 3) and thus comparable to those of the standard drugs tacrine  
and propidium. 
Table 3. Human AChE inhibitory effects and anti-oxidant activities for compounds 1–6. 
Compounds 
Molecular 
weight 
AChE Inhibition (%) 
(Final conc. = 1 × 10−4 M) 
DPPH 
(IC50, μg/mL) 
FRAP value 
(Mean ± SD) 
1 184.15 38.0 ± 1.3 1.210 ± 0.002 81,633.30 ± 0.075 
2 381.18 77.0 ± 1.8 1.140 ± 0.001 62,200.00 ± 0.083 
3 336.73 68.9 ± 1.8 1.400 ± 0.002 35,740.00 ± 0.011 
4 332.31 48.5 ± 2.5 1.220 ± 0.001 30,080.00 ± 0.054 
5 287.27 16.4 ± 1.4 1.460 ± 0.001 22,946.70 ± 0.004 
6 329.31 71.5 ± 1.7 2.300 ± 0.001 23,340.00 ± 0.021 
Propidium - 54.5 ± 1.6  - - 
Tacrine - 51.2 ± 1.6  - - 
Ascorbic acid - - 2.260 ± 0.001 19,400.00 ± 0.007 
BHT - - - 187.3 ± 2.6 
1: Gallic hydrazide; 2: N-(1-(5-Bromo-2-hydroxyphenyl)-ethylidene)-3,4,5-trihydroxybenzohydrazide; 
3: N-(1-(5-Chloro-2-hydroxyphenyl)-ethylidene)-3,4,5-trihydroxybenzohydrazide; 4: N-(1-(2-Hydroxy- 
5-methoxyphenyl)-ethylidene)-3,4,5-trihydroxybenzohydrazide; 5: 3,4,5-Trihydroxybenzoic acid 
[1-pyridylethylidene] hydrazide, 6: 3,4,5-Trihydroxybenzoic acid [1-(4-acetyl-pyridin-2-yl)-ethylidene] 
hydrazide; BHT: Butylated hydroxytoluene. 
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Compounds 2, 3 and 6 showed the highest activities. This indicates that introduction of chlorine or 
bromine atom at position 5 of the acetophenone moiety significantly enhances the inhibition activity. 
This might be ascribed to the electron donating properties of the halogens by resonance, making the 
lone pair electrons more available to a plausible electron transfer. The activity of 6 could be attributed 
to the presence of the acetyl group on the pyridine ring making the lone pair electron on the pyridine 
nitrogen atom available for electron transfer, also increasing of bond dissociation enthalpy (BDE) 
values in phenolic structure contain substituent of electron withdrawing groups such as COR, COOR, 
CN [23] could discourage the abstraction of hydrogen. O-H bond dissociation enthalpy (BDE) is a 
theoretical parameter successfully used to measure the H-atom-donating ability of various antioxidants. 
Similar results have been reported by Kadoma [24]. 
2.4. Molecular Docking 
The crystal structure of hAChE (in complex with fasciculin-2) (pdb id: 1B41) shows that the 
enzyme possesses a deep narrow gorge which penetrates halfway into the enzyme, where the catalytic 
site resides [25]. The binding site of AChE consists of five subsites: a peripheral anionic site (PAS), an 
acyl binding pocket (ABP), the esteratic site (ES), an oxyanion hole (OH) and an anionic subsite (AS). 
Figure 2. Representations of the molecular model of the complex formed between 
compound 2 and hAChE. (a) 3D representation of the ligand-enzyme binding interactions. 
Compound 2 is represented as a dark grey sticks and hydrogen bonds as green dashed lines; 
(b) 2D schematic representation of the hydrogen bonding and hydrophobic interactions. 
 
a 
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Figure 2. Cont. 
 
b 
The residues that have been reported to be involved in protein-ligand interactions are Tyr 72,  
Asp 74, Tyr 124, Ser 125, Trp 286, Tyr 337 and Tyr 341 (PAS); Trp 236, Phe 295, Phe 297 and  
Phe 338 (ABP); Ser 203, His 447 and Glu 334 (ES); Gly 121, Gly 122 and Ala 204 (OH); and Trp 86, 
Tyr 133, Glu 202, Glu 448 and Ile 451 (AS) [26]. The molecular docking simulation of the complex 
formed between compound 2 and hAChE (Figure 2) showed the ligand well positioned in the active-site 
gorge, with the monohydroxyphenyl and trihydroxyphenyl moieties interacting with residues in the 
PAS and ABP, respectively. 
A closer inspection of the interactions at the PAS showed the presence of a hydrogen bond between 
the 2-hydroxyl group and Tyr 72, π-π stacking involving the monohydroxyphenyl ring, Trp 286 and  
Tyr 341 and a cation-π interaction between the protonated nitrogen atom of the amide and Trp 286. 
Furthermore, hydrophobic interactions between 2 and the rich aromatic residues (Asp 74, Tyr 124,  
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Trp 286, Leu 289 and Tyr 341) along the gorge appear to direct the trihydroxyphenyl moiety into the 
ABP, thus enabling the phenolic hydroxyl groups to form a network of hydrogen bonds with Ser 293, 
Phe 295 and Arg 296. 
Molecular modeling of the complexes formed between the enzyme and compounds 3 and 6 
suggested the involvement of a similar set of interactions as for the complex with compound 2  
(see Figures 3 and 4). In the case of the complex with compound 3, the model showed, at the PAS, a 
hydrogen bond between the 2-hydroxyl group and Asp 74, a σ-π interaction between carbon 6 in the 
aromatic ring and Trp 286, a cation-π interaction between the protonated nitrogen atom of the amide 
and Tyr 341 and a hydrogen bond between the amide nitrogen atom and Tyr 124 and, in the ABP, 
hydrogen bonds between two of the hydroxyl groups in the trihydroxyphenyl moiety and Ser 293 and 
Arg 296. The complex with compound 6 showed, at the PAS, π-π stacking between the pyridinyl ring 
and Trp 286 and hydrogen bonds between the amide nitrogen atom and the carbonyl group and  
Arg 296 and, in the ABP, hydrogen bonds between of the hydroxyl groups in the trihydroxyphenyl 
moiety and Tyr 337 and Phe 338. 
Figure 3. Representations of the molecular model of the complex formed between 
compound 3 and hAChE. (a) 3D representation of the ligand-enzyme binding interactions. 
Compound 3 is represented as a dark grey sticks and hydrogen bonds as green dashed lines; 
(b) 2D schematic representation of the hydrogen bonding and hydrophobic interactions. 
 
a 
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Figure 3. Cont. 
 
b 
This analysis suggests that the hAChE inhibition activity of compounds 2, 3 and 6 is probably due 
to their ability to block the active-site gorge, thus preventing the substrate, acetylcholine, from entering 
the active site. 
2.5. Antioxidant Assays 
The antioxidant efficacies of the compounds 1–6 were tested and the results obtained (see Table 3) 
revealed differing activities in the two assays. This indicates that two mechanisms, operating in 
different ways, must be responsible for the observed activity. The color change from deep purple to 
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yellow at 515 nm observed in the DPPH assay confirmed the radical scavenging activity of the 
compounds. A reference curve of absorbance (A) against DPPH concentration in methanol was plotted 
and used for the calculation of DPPH concentration at various reaction times (R2 = 0.9999). The 
compounds showed IC50 values in the range of 1.1–2.3 μg/mL. All the compounds tested showed a 
lower IC50 compared to the positive control used (ascorbic acid), except for compound 6, which 
showed no significant difference with the IC50 of the positive control. The high activity of the 
compounds in the DPPH assay can be related to the resonance effect of the polyhydroxyl groups 
attached to the phenolic ring in the compounds, whereupon electron donating substituents increase the 
electron density in the aromatic ring making it more reactive towards electrophilic attack or mainly 
due to their redox properties, which can play an important role in the absorption and neutralization of 
free radicals, the quenching of singlet and triplet oxygen, or the decomposition of peroxides [27,28]. 
This presumably promotes the release of phenolic hydrogen to the (1,1-diphenyl-2-picrylhydrazyl) free 
radical indicated by a color change from purple to yellow. The second method used for testing  
the antioxidant activities of these compounds was the FRAP assay. It is considered an accurate method 
for assessing “antioxidant power”. Ferric to ferrous ion reduction at low pH causes a colored  
ferrous-tripyridyltriazine complex to form. FRAP values are obtained by comparing the absorbance 
change at 593 nm in test reaction mixtures with those containing ferrous ions at known concentrations. 
Figure 4. Representations of the molecular model of the complex formed between 
compound 6 and hAChE. (a) 3D representation of the ligand-enzyme binding interactions. 
Compound 6 is represented as a dark grey sticks and hydrogen bonds as green dashed lines; 
(b) 2D schematic representation of the hydrogen bonding and hydrophobic interactions. 
 
a 
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Figure 4. Cont. 
 
b 
In this study, the compounds showed FRAP values in the range 2,000–9,000 which is above the values 
shown by BHT and ascorbic acid used as standards. It was observed that compounds 1–5 demonstrated the 
highest activities in the DPPH assay while 1 and 2 showed the highest values in the FRAP assay. This can 
be attributed to increased π-electron delocalization within the pyridine ring which increases the electron 
density and causes ferric ion reduction [29]. 
3. Experimental Section 
3.1. General 
The compounds synthesized in this study were characterized by spectral methods. IR spectra was 
recorded at the wavelength range from 4,000–400 cm−1 using a Perkin Elmer 783 spectrophotometer, 
NMR spectra were obtained on a ECA400 FT-NMR spectrophotometer using TMS as internal 
standard, UV-visible spectra were recorded on a UV-1650PC model UV-visible spectrophotometer, 
Melting points were measured using a Gallenkamp melting point apparatus and are Elemental analysis 
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was conducted on Costech Elemental Combustion System CNHS-O elemental analyzer. General grade 
solvents and reagents were used unless stated otherwise and were obtained from Aldrich Chemicals 
UK Ltd. and Acros Ltd. (UK). Methyl-3,4,5-trihydroxybenzoate, hydrazine hydrate, 2-hydroxy-5-
methoxyacetophenone, 5-bromo-2-hydroxyacetophenone, 5-chloro-2-hydroxyacetophenone, 2-cetylpyridine, 
2,6-diacetylpyridine, Dilute Hydrochloric acid (0.01 M), Distilled Ethanol. Distilled water and 
Dimethyl formamide (DMF). 
3.2. Gallic Hydrazide (1) 
 
N
H
O
NH2
HO
HO
HO Molecular Weight: 184.15  
An ethanolic solution (20 mL) containing methyl 3,4,5-trihydroxybenzoate (1.84 g, 0.01 M C8H8O5) 
and hydrazine (9 mL) was stirred for 30 minutes, until all the solute completely dissolved then distilled 
ethanol (45 mL) was added. The mixture was refluxed for about 6–8 h. The resulting white precipitate 
was collected by filtration, washed several times with distilled water and then dried under vacuum. 
Yield = 70%, melting point = 290 °C, elemental analysis theory: C (45.6%); H (4.3%); N (15.2%); 
found: C (45.2%); H (5.04%); N (15.04%), %, FT-IR spectra (KBr); 3,429 cm−1 (νAr-OH), 3,299 cm−1 
(νN-H), 1,654 cm−1 (νC=O), 1,344cm−1 (νC-O), 1,103 cm−1 (νN-N), 1H-NMR (DMSO-d6): 9.35 ppm 
[δ(Ar-OH), 1H s], 9.13 ppm, 9.05 ppm [δ(Ar-OH), 2H, d], 8.65 ppm [δ(NH), 1H, brd], 6.79 ppm,  
6.82 ppm [δ(Ar-H), 2H s], 4.37 ppm [δ(NH2), 2H s]. 13C-NMR (DMSO-d6): 166.39 ppm [δ(CONH), 
1C], 145.37 ppm [δ(aromatic), 1C-OH], 136.10, 136.42 ppm [δ(aromatic), 2C-OH], 124.00 ppm 
[δ(aromatic), 1C], 106.43 ppm [δ(aromatic), 2C = C] ppm. 
3.3. N-(1-(5-Bromo-2-hydroxyphenyl)-ethylidene)-3,4,5-trihydroxybenzohydrazide (2) 
N
H
OHO
HO
HO
N
CH3
HO
Br
Molecular Weight: 381.18  
Gallic hydrazide (1.84 g, 0.01 M) in (20 mL) ethanol was added to an ethanolic solution (20 mL) of 
5-bromo-2-acetophenone (2.15 g, 0.01 M respectively). The mixture was stirred for 2–3 h whereupon 
the color of the solution turned yellowish. The pH was adjusted by adding a few drops of dilute HCl. 
The reaction was continued for another hour resulting in the formation of a yellow precipitate. More 
precipitate was obtained when reducing the solvent by distillation. The product was collected by 
filtration, washed several times with ethanol and dried in an oven. (Yield 75%), elemental analysis: 
theory C (47.50); H (3.89); N (7.32); found C (47.26); H (3.44); N (7.35); IR spectra (KBr);  
3,558 cm−1 (νAr-OH), 3,235 cm−1 (νN-H), 1,604 cm−1 (νC=N), 1,658 cm−1 (νC=O), 1,242 cm−1  
(νC-O), 953 cm−1 (νN-N), 1H-NMR (DMSO-d6): 13.57 ppm [δ(OH), 1H, s], 11.10 ppm [δ(OH), 1H, s], 
9.05 ppm [δ(OH), 2H, brd], 6.79–7.73 ppm [δ(aromatic), 5H, m], 4.34 ppm [δ(NH), 1H, s], 1.24 ppm 
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[δ(-CH3 ), 3H, s]. 13C-NMR (DMSO-d6): 166.39 ppm [δ(C=N)], 164.43 ppm [δ(C=O)], 145.53 ppm, 
145.36 ppm [δ(aromatic), 2C-OH], 137.41 ppm [δ(aromatic), 1C-OH], 137.40, 136.10 ppm, 
[δ(aromatic), 2C], 130.31 ppm [δ(aromatic), 1C], 123.51 ppm, 122.35 ppm, 121.52 ppm, 119.50 ppm 
[δ(aromatic), 4C], 107.54 ppm, 106.42 ppm [δ(aromatic), 2C=C], 13.92 ppm [δ(CH3)] ppm. 
3.4. N-(1-(5-Chloro-2-hydroxyphenyl)-ethylidene)-3,4,5-trihydroxybenzohydrazide (3) 
N
H
OHO
HO
HO
N
CH3
HO
Cl
Molecular Weight: 336.73  
An accurately weighed amount of gallic hydrazide (1.84 g, 0.01 M) in ethanol (20 mL) was added 
to the same ethanolic solution (20 mL) of 5-chloro-2-hydroxyacetophenone (2.15 g, 0.01 M), and the 
mixture was stirred for 2–3 h as the color of the solution turned yellowish. The pH was adjusted by 
adding few drops of dilute HCl. The reaction was continued for another 1 h to give a yellow 
precipitate. More precipitate was obtained after reducing the solvent by distillation. The product was 
collected by filtration, washed several times with ethanol and dried in an oven. (Yield 75%) 
respectively, elemental analysis: theory C (53.50); H (3.89); N (8.32); found C (53.39); H (3.76);  
N (8.33); IR spectra (KBr); 3,568 cm−1 (νAr-OH), 3,225 cm−1 (νN-H), 1,638 cm−1 (νC=O), 1,604 cm−1 
(νC=N), 1,212 cm−1 (νC-O), 953 cm−1 (νN-N). 1H-NMR (DMSO-d6): 11.14 ppm [δ(OH), 1H, s],  
11.13 ppm [δ(OH), 1H, s], 9.30 ppm [δ(OH), 2H, brd], 7.66 ppm [δ(NH), 1H, s], 7.37–6.93 ppm 
[δ(aromatic), 3H, m], 6.983 ppm, 6.976 ppm [δ(aromatic), 2H str d], 2.12 ppm [δ(-CH3), 3H, s].  
13C-NMR (DMSO-d6): 166.94 ppm [δ(C=N)], 164.84 ppm [δ(C=O)], 157.94 ppm [δ(aromatic) 1C], 
146.10 ppm, 145.93 ppm [δ(aromatic), 2C-OH], 137.97 ppm [δ (aromatic), 1C-OH], 128.10 ppm, 
124.08 ppm, 122.92 ppm, 122.53 ppm, 121.48 ppm, 119.58 ppm [δ(aromatic), 6C], 108.10 ppm, 
106.98 ppm [δ(aromatic), 2C=C], 14.48 ppm [δ(CH3)] ppm. 
3.5. N-(1-(2-Hydroxy-5-methoxyphenyl)-ethylidene)-3,4,5-trihydroxybenzohydrazide (4) 
N
H
OHO
HO
HO
N
CH3
HO
O
CH3
Molecular Weight: 332.31  
An ethanolic solution (20 mL) of gallic hydrazide (1.84 g, 0.01 M) was added to an ethanolic 
solution (20 mL) of 2-hydroxy-5-methoxyacetophenone (1.06 g, 0.01 M) in 1:1 ratio. The mixture was 
refluxed for 2–3 h resulting in the formation of a slightly yellow precipitate. More precipitate was 
obtained by removal of some solvent by distillation. The product was collected by filtration, washed 
several times with ethanol until a milky colored compound is obtained. The ligand was re-crystallized 
by using the same solvent (ethanol), filtered to remove the suspended impurities and a single crystal 
was obtained suitable for X-ray analysis. (Yield = 65%), elemental analysis: theory C (57.83);  
H (4.85); N (8.43); found C (58.30); H (4.51); N (8.71); IR spectra (KBr); 3,467 cm−1 (νAr-OH),  
3,308 cm−1 (νN-H), 1,650 cm−1 (νC=O), 1,623 cm−1 (νC=N), 1,282 cm−1 (νC-O), 944 cm−1 (νN-N),  
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1H-NMR (DMSO-d6): 12.89 ppm [δ(OH)], 10.98 ppm [δ(OH), 1H, s], 9.28 ppm [δ(OH), 2H, brd], 
8.90 ppm [δ(NH)], 7.11 ppm [δ(aromatic), 2H str s], 7.11–6.83 ppm [δ(aromatic), 3H, m], 3.75 ppm 
[δ(O-CH3), 3H, s], 1.24 ppm [δ(-CH3), 3H, s]. 13C-NMR (DMSO-d6): 152.58 ppm [δ(C=N)],  
151.36 ppm [δ(C=O)], 145.52 ppm [δ(aromatic), 2C-OH], 137.27 ppm [δ(aromatic), 1C-OH],  
122.70 ppm, 122.61 ppm, 117.77 ppm, 117.39 ppm, 119.49 ppm [δ(aromatic), 5C], 107.44 ppm 
[δ(aromatic), 2C=C], 55.54 ppm [δ(O-CH3)], 13.94 ppm [δ(CH3)] ppm. 
3.6. 3,4,5-Trihydroxybenzoic Acid [1-Pyridylethylidene] Hydrazide (5) 
N
H
OHO
HO
HO
N
CH3
N
Molecular Weight: 287.27  
A stoichiometric amount of gallic hydrazide (1.84 g, 0.01 M) in ethanol (20 mL) was added to a 
solution (20 mL) of 2-acetylpyridine (1.21 mL, 0.01 mmol) and the mixture was refluxed on a water 
bath for 2–3 h, resulting in the formation of a small amount of white precipitate. More precipitate was 
obtained after evaporating the solvent by distillation. The product was then collected by filtration, 
washed several times with ethanol until a clear white powdery product was formed. The white 
powdered ligand was recrystallized by using DMF to obtain single crystals for X-ray structural 
determination. (Yield = 65%), melting point = 253 °C, elemental analysis: theory: C (58.53%); H (4.56%); 
N (14.63%); found: C (57.99%); H (4.56%); N (14.06%), IR spectra (KBr); 3,399 cm−1 (νAr-OH), 
3,351 cm−1 (νN-H), 1,621 cm−1 (νC=N), 1,618 cm−1 (νC=O), 1,560 cm−1 (νC=N)Py, 1,281 cm−1  
(νC-O), 1,032 cm−1 (νN-N), 1H-NMR (DMSO-d6): 9.38 ppm [δ(OH), 1H, s], 9.21 ppm, 9.11 ppm 
[δ(OH), 2H, brd], 8.14–8.07 ppm [δ(aromatic), 2H m], 7.87–7.70 ppm [δ(aromatic), 2H m], 7.63 ppm 
[δ(NH), 1H, s, brd], 6.92 ppm [δ(aromatic), 2H str s], 1.24 ppm [δ(-CH3), 3H, s]. 13C-NMR  
(DMSO-d6): 162.47 ppm [δ(C=N)], 155.25 ppm [δ(C=O)], 148.54 ppm [δ(aromatic), pyridine],  
145.85 ppm [δ (aromatic), 2C-OH], 138.70 ppm [δ(aromatic), 1C-OH], 136.52 ppm [δ(aromatic), 
pyridine], 124.57 ppm [δ(aromatic), 1C], 123.95 ppm, 122.90 ppm [δ(aromatic), pyridine],  
107.55 ppm, 106.35 ppm [δ (aromatic), 2C=C], 22.10 ppm [δ(CH3)] ppm. 
3.7. N'-(1-(6-Acetylpyridin-2-yl)ethylidene)-3,4,5-trihydroxybenzohydrazide (6) 
 
N
H
OHO
HO
HO
N
CH3
N
O
CH3
Molecular Weight: 329.31  
A weighed amount of gallic hydrazide (1.84 g, 0.01 M) in (20 mL) ethanol was added to the same 
volume (20 mL) of ethanolic solution of 2,6-diacetylpyridine (1.63 g, 0.01 M). The mixture was stirred 
for 2–3 h while the color of the solution turned yellowish. The pH was adjusted by adding few drops of 
dilute HCl. The reaction was continued for another one hour resulting in the formation of a yellow 
precipitate. The product was collected by filtration, washed several times with ethanol and dried in an 
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oven. (Yield 90%), elemental analysis: theory C (58.36); H (4.59); N (12.76); found: C (57.99);  
H (4.89); N (13.11); IR spectra (KBr); 3,448 cm−1 (νAr-OH), 3,239 cm−1 (νN-H), 1,674 cm−1 (νC=O), 
1,610 cm−1 (νC=N), 1,511 cm−1 (νC-N)py, 1,265 cm−1 (νC-O), 955cm−1 (νN-N). 1H-NMR (DMSO-d6): 
9.29 ppm [δ(OH), 1H, s], 8.26 ppm, 8.28 ppm [δ(OH), 2H, brd], 8.14–8.03 ppm [δ(aromatic), 2H m], 
8.01–7.90 ppm [δ(aromatic), 2H m] 6.89 ppm [δ(aromatic), 2H str s], 4.3 ppm [δ(NH), 1H, s], 1.19 ppm 
[δ(-CH3), 3H, s]. 13C-NMR (DMSO-d6): 166.38 ppm [δ(C=N)], 164.34 ppm [δ(C=O)], 151.97 ppm 
[δ(aromatic), pyridine], 145.37 ppm [δ(aromatic), 2C-OH], 137.87 ppm [δ(aromatic) 1C-OH],  
136.13 ppm [δ(aromatic), pyridine], 123.87 ppm [δ(aromatic), 1C], 123.51 ppm [δ(aromatic), 2C=C], 
121.13 ppm, 120.26 ppm [δ(aromatic), pyridine], 199.24 ppm, 106.45 ppm [δ(C=OCH3)], 25.50 ppm 
[δ(CH3-C=O)], 18.52 ppm [δ(CH3)] ppm. 
3.8. X-ray Crystallography 
Diffraction data were measured using a Bruker SMART Apex II CCD area-detector diffractometer 
(graphite-monochromated Mo K radiation, = 0.71073 Å). The orientation matrix, unit cell refinement 
and data reduction were all handled by the Apex2 software (SAINT integration, SADABS absorption 
correction) [30]. The structures were solved using direct or Patterson methods in the program 
SHELXS-97 [31] and were refined by the full matrix least-squares method on F2 with SHELXL-97. 
All the non-hydrogen atoms were refined anisotropically and all the C-bound hydrogen atoms were 
placed at calculated positions and refined isotropically. O-bound hydrogen atoms were located in 
difference Fourier maps and refined with distance restraint of O-H 0.84(2) Å. Drawings of the 
molecules were produced with XSEED [32]. Crystal data and refinement are summarized in Table 2. 
3.9. Anti-AChE Assay 
The anti-cholinesterase activities of the compounds were evaluated by Ellmann’s method with 
slight modifications, using acetylthiocholine as a substrate [33] and 5,5'-dithiobis[2-nitrobenzoic 
acid](DTNB). Sodium phosphate buffer (pH 8.0, 110 μL) was added into the 96 wells followed by 
sample solution (20 μL), DTNB (0.126 mM, 50 μL) and AChE enzyme (0.6 U/mL, 20 μL). The 
mixture was incubated for 50 minutes at 37 °C. The reaction was then initiated by the addition of 
acetylthiocholine iodide (0.120 mM, 50 μL). The hydrolysis of acetylthiocholine was monitored by  
the formation of yellow 5-thio-2-nitrobenzoate anion as the result of the reaction of DTNB with 
thiocholine, released by the enzymatic hydrolysis of acetylthiocholine, at a wavelength of 412 nm 
every 30 s for 25 minutes using a 96-well microplate plate reader (TECAN Infinite M200, Mannedorf, 
Switzerland). Test compounds were dissolved in analytical grade DMSO. Tacrine and propidium 
iodide were used as reference standards [34]. The reactions were performed in triplicate and monitored 
with a spectrophotometer. The percent inhibition of the enzyme activity due to the presence of 
increasing test compound concentration was obtained from the expression; 100 − (vi/vo × 100), where 
vi is the initial rate calculated in the presence of inhibitors and vo is the enzyme activity. 
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3.10. Molecular Modeling Evaluations 
The coordinates for the enzyme were those deposited in the Protein Data Bank for the human 
acetylcholinesterase (1B41) after eliminating the inhibitor (Fasciculin-2) and water molecules. The 
missing residues were built and polar hydrogen atoms were added using Discovery Studio 3.0 
(Accelrys, Inc., San Diego, CA, USA). By default, solvation parameters and Kollman charges were 
assigned to all atoms of the enzyme using AutoDock Tools v.1.4. The 3D structures of the compounds 
were optimized according to the standard protocol in Discovery Studio 3.0. For docking studies, the 
latest version of AutoDock v.4.0 [35] was chosen because its algorithm allows full flexibility of small 
compounds. It has been shown to successfully reproduce many crystal structure complexes and 
includes an empirical binding free energy evaluation. Docking of compounds to AChE was carried out 
using the hybrid Lamarckian Genetic Algorithm. A grid box with the size of 178 Å × 200 Å × 194 Å 
and grid spacing of 0.375 Å was built to span the entire protein structure, in vacuo. The maximum 
number of energy evaluations was set to 25,000,000. Blind docking was used to predict structural 
features of compound binding. Resulting docked orientations within a root-mean square deviation of 
1.5 Å were clustered. The lowest energy cluster reported by AutoDock for each compound was used 
for further analysis. All other parameters were maintained at their default settings. The structures of 
the complexes obtained were visualized and analyzed using Discovery Studio 3.0 and Ligplot 1.0 [36] 
to identify some specific interactions between the atoms of the compounds and the enzyme. 
3.11. Antioxidant Activity 
3.11.1. DPPH (1,1-Diphenyl-2-picrylhydrazyl) Assay 
The scavenging activities of the compounds on DPPH were measured according to a reported 
procedure [37]. The compounds showed final concentrations within the range of 0–25 μg/mL in 
methanol. One milliliter of 0.3 mM DPPH ethanol solution was added to sample solution (2.5 mL) of 
different concentrations and used as stock solutions for the test; meanwhile methanol (1 mL) was 
added to samples (2.5 mL) to make the blank solutions. The negative control (blank) consisted of 
DPPH solution (1 mL) plus methanol (2.5 mL). These solutions were allowed to react at room 
temperature for 30 min in the dark. The absorbance was read at 518 nm and converted into percentage 
antioxidant activity according to the following equation: % Inhibition = [(AB − AA)/AB] × 100. 
Where: AB: absorption of blank sample, AA: absorption of tested samples. The kinetics of DPPH 
scavenging activity was determined and the IC50 calculated using ascorbic acid as a positive control. 
3.11.2. FRAP Assay 
The FRAP assay of the compounds performed using modified method as described by Benzie and 
Strain [38]. The stock solutions contained 300 mM acetate buffer (3.1 g CH3COONa·3H2O and 16 mL 
CH3COOH), pH 3.6, 10 mM TPTZ (2,4,6-tripyridyl-s-triazine) solution in 40 mM hydrochloric acid 
and 20 mM ferric chloride hexahydrate solution. The fresh working solution was prepared by mixing 
acetate buffer (25 mL), TPTZ (2.5 mL), and ferric chloride hexahydrate solution (2.5 mL). The 
temperature of the solution was raised to 37 °C before use and allowed to react with the FRAP solution 
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(300 μL) in the dark. The colored product (ferrous tripyridyltriazine complex) was monitored at a 
wavelength of 593 nm. The standard curve was linear between 100 and 1,000 μM ferrous sulphate. 
Results are expressed in μM ferrous/g dry mass and compared with that of ascorbic acid and  
butylated hydroxytoluene. 
3.12. Statistical Analysis 
All values were reported as mean ± S.E.M. The statistical significance of differences between 
groups was assessed using one-way ANOVA. A value of p < 0.05 was considered significant. 
4. Conclusions 
Synthesized novel Schiff bases were observed to be potentially useful for acetyl-cholinesterase 
inhibition and possible treatment for AD. The compounds also showed strong free radical inhibitory 
activities. In silico molecular modeling revealed that the compounds may position themselves in the 
enzyme’s active-site gorge, interacting with residues in the peripheral anionic subsite (PAS) and acyl 
binding pocket (ABP). 
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CCDC 857032 contains the supplementary crystallographic data for complex-4. These data can be 
obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: (+44) 1223-336-033;  
or E-Mail: deposit@ccdc.cam.ac.uk. Detailed information can be accessed at: http://www.mdpi.com/ 
1420-3049/17/3/2408/s1. 
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